"More than 7000 individuals experience cardiac arrest each year in Denmark alone and only 20 percent survive the incident which highlights the importance of our efforts to identify new and effective interventions to improve outcomes for these patients.” 

For Professor Lars Wiuff Andersen, the objective is clear: To improve the chance of survival for people experiencing cardiac arrest.

Through clinical trials, cohort studies and extensive reviews of previous studies, he is dedicated to advancing our understanding of the condition and gain knowledge about how best to treat patients.

Lars Wiuff Andersen and his research team are currently engaged in several projects, including two clinical trials: a comparative effectiveness trial examining the optimal approach to administering medication to patients with out-of-hospital cardiac arrest. And an efficacy trial involving 22 hospitals across Denmark evaluating the impact of bicarbonate administration during in-hospital cardiac arrest on patient outcomes. Both trials will enroll a large a large number of patients, over 1200 and 700 respectively.

Lars Wiuff Andersen’s passion for this field stems from his fascination of the critical nature of decision making and treatment in acute medical conditions. His commitment to advancing the field is evidenced by his group’s publication of two trials in JAMA and presentation of results at the Critical Care Reviews meeting in 2021.

“Cardiac arrest is the most acute condition we see as doctors, and it was therefore a natural field of research for me. But research is a team sport, and the success of our efforts to improve outcomes for patients with cardiac arrest relies heavily on the collaboration and contributions of many individuals who share a commons goal of advancing our understanding of this critical condition.”

• Learn more about Lars Wiuff Andersen’s research on Researchgate